"Exploring the Impact of Cancer on Heart Health ❤️🩹
Within the realm of cancer treatment, the potential for Cancer Therapeutics-Related Cardiac Dysfunction (CTRCD) looms as a recognized complication arising from the use of chemotoxic agents. In the echocardiography sphere, where I proudly contribute, CTRCD takes on a specific definition: a significant decrease of over 10 percentage points in the Left Ventricular Ejection Fraction (LVEF), resulting in a value falling below 53%. This decline is to be confirmed through repeated cardiac imaging.
In the echocardiography laboratory I'm part of, a specialized team of us undertakes the meticulous examination of consecutive echocardiograms for patients undergoing or planning to undergo chemotherapy. By harnessing the power of strain imaging—a unique echocardiographic parameter—we're empowered to identify subtle declines in ventricular function even before the ejection fraction shows substantial drops. This critical capability empowers oncologists and cardiologists to initiate proactive interventions prior to any onset of cardiac decompensation. Such early interventions are pivotal in ensuring the comprehensive care of these patients.
It's worth noting that the article includes captivating strain images and a compelling "bullseye plot" showcasing the results of a patient's surveillance study."
Article by: Dr. Koh Choong Hou - Consultant Cardiologist - National Heart Centre, Singapore.
No comments:
Post a Comment